Finnish biotech NADMED raised $3.5M in Series A funding led by Nordic Science Investments to bring CE-marked NAD testing kits to the market.
Amount Raised
$3.5 Million
Round Type
Series A
HelsinkiBiotechnologyHealth CareInvestors
Description
NADMED has secured $3.5 million in Series A funding to enter into the US and other international markets with its proprietary NAD measurement technology. The funding round was led by Nordic Science Investments, along with contributions from previous investors and a Business Finland grant.
Quick answer
NADMED raised $3.5 Million in a Series A round, dated August 22, 2024. Investors: University Of Helsinki Funds, Voima Ventures and Nordic Science Investments. NADMED is based in Helsinki, Uusimaa, Finland.
- How much did NADMED raise?
- NADMED raised $3.5 Million in a Series A round on August 22, 2024.
- Who invested in NADMED?
- University Of Helsinki Funds, Voima Ventures and Nordic Science Investments are named as investors in this round.
- What does NADMED do?
- NADMED Oy is a startup company bringing to market a new accurate high-throughput method to measure NADs from whole blood and other sample matrices.
- Where is NADMED based and how big is it?
- NADMED is based in Helsinki, Uusimaa, Finland.
- Who are the decision-makers at NADMED?
- Fundz holds 1 contact at NADMED. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as NADMED that raised within 45 days of this round, from Fundz verified event records.
- Medeloop raised $15M on October 4, 2024.
- Ai Health Highway raised $1M (Pre-Series A) on October 4, 2024.
- ProEncia Biotechnology raised $1.5M (Pre-Seed) on October 4, 2024.
- Oncare raised $1M (Seed) on October 3, 2024.
- Insight Molecular Diagnostics Inc. raised $10M on October 2, 2024.
- Xeptiva raised $2.5M (Seed) on October 2, 2024.
Who to call at NADMED, and when
A new round usually means NADMED is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NADMED raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NADMED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NADMED. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NADMED raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNADMED raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.